APA (7th ed.) Citation

T, Y., H, O., Y, G., & M, K. (2026). Administration of tirabrutinib suspension in a patient with primary central nervous system lymphoma: A case report. Oncology letters, 31(5), 176. https://doi.org/10.3892/ol.2026.15531

Chicago Style (17th ed.) Citation

T, Yasu, Ohta H, Gando Y, and Kobayashi M. "Administration of Tirabrutinib Suspension in a Patient with Primary Central Nervous System Lymphoma: A Case Report." Oncology Letters 31, no. 5 (2026): 176. https://doi.org/10.3892/ol.2026.15531.

MLA (9th ed.) Citation

T, Yasu, et al. "Administration of Tirabrutinib Suspension in a Patient with Primary Central Nervous System Lymphoma: A Case Report." Oncology Letters, vol. 31, no. 5, 2026, p. 176, https://doi.org/10.3892/ol.2026.15531.